N. Y. Acad. Sci. 277: 355, 1976. ROSENTHAL, M., U. TRABERT AND W. MULLER. The effect of levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis. Emergencies DICE session organised by the Romanian WG on Echocardiography Chairpersons: I.M. Coman Bucharest, RO M. Penco L'Aquila, IT ; 08: 30 Expected and unexpected events in a newborn with double - outlet right ventricle. R. Toganel TG. Mures, RO ; 08: 41 Echocardiography as a diagnostic tool in a case with acute dyspnoea. M. Dorobantu Bucharest, RO ; 08: 52 The Halley's comet effect in echocardiography: what is the impact? B.A. Popescu Bucharest, RO ; 09: 03 Cardiac failure after myocardial infarction. D.-C. Bedeleanu Cluj-Napoca, RO ; 09: 14 A chest pain story: Hurry . but don't worry ! I.M. Coman Bucharest, RO ; 09: 25 Insights into disease history using echocardiographic clues in a patient with acute dyspnea. D.C. Cozma Timisoara, RO ; 09: 36 Echo pitfalls in the management of acute pulmonary edema. C. Gherghinescu Bucharest, RO ; 09: 48 Iatrogenic acute tricuspid regurgitation. E. Apetrei Bucharest, RO. The chromatographic analysis of levamisole and its internal standard was done according to El-Kholy and Kemppainen, 2003. The column was Luna7 5 C18 150 mm 4.6 mm and the mobile phase consisted of one liter 2% acetic acid in water: methanol 50: v v ; and one bottle of PIC B-7 low UV reagent. The pH of the mobile phase was adjusted to 7.31 with concentrated ammonium hydroxide solution. Flow rate was 1 ml min. The UV detection was at wavelength of 225 nm. Oncology - ergamisol levamisole hydrochloride ; for colon cancer, leustatin cladribine ; for hairy cell leukemia and doxil doxorubicin ; , an anti-cancer treatment. Effects reported Drug Facts and Comparisons, 1999 ; . There were almost 13, 000 animals treated for exposure to ivermectin in reports to FDA's CVM from 1987-1997 the compilation contained no mention of human exposures, possibly because it does not track topically applied, externally acting parasiticides - the formulation most likely to result in accidental human exposure ; . Results of accidental overdosing with ivermectin containing veterinary products indicate that the acute signs and symptoms are similar in man as those observed in laboratory animals but require much higher doses. The primary food safety concern for ivermectin is related to its neurotoxic effects; the new ADI for ivermectin based on this effect is 1 microgram kilogram day NADA, 1995 ; . Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ivermectin. Ivermectin was not genotoxic by the Ames test and had no adverse effects on fertility in rats. Although there are no adequate studies in pregnant women, ivermectin has been classified as Pregnancy Category C teratogen based on studies in mice, rats, and rabbits Physicians Desk Reference, 1998 ; . In general, the relative safety from acute effects of parasiticides, in general, for humans from incidental exposure seems to be borne out by statistics from the 1997 annual report of the American Association of Poison Control Centers that contained reports of over 2 million human poisonings reported in 1997. Of 3, 500 poisonings attributed to anthelmintics and antiparasitics classified as related to exposure to DEC, piperazine, metronidazole, antimalarials, other, or unknown ; , there were about 1, 000 reports that could potentially have been related to the chemicals being discussed. Of those, there was only 1 death, 0 major health outcomes, 37 moderate health outcomes, and the rest were minor or no health outcome 96% ; . Levamisole Levamisole has the narrowest margin of safety of the three, with intoxication that mimics organophosphate toxicity. However, because Levamisole is used in chemotherapy for cancer patients, it is considered safe for humans. Levamisole can cause prolonged prothrombin time in patients taking coumarin-like drugs and has been associated with sporadic cases of encephalopathy-like syndrome Mosby, 1997 ; . Levamisole may produce an "Antabuse" reaction nausea, vomiting, headache, dizziness, faintness, mental confusion, dyspnea, chest and abdominal pain, profuse sweating, and skin rash ; with concomitant alcohol ingestion. It is excreted in cow's milk and considered to represent the potential for serious adverse reactions for infants. Adverse reactions noted most frequently in a study of 440 adverse events were: dermatitis, fatigue, nausea, diarrhea, vomiting, taste perversion, arthalgia, and infection. Label warnings for the human drug include: agranulocytosis s with flu-like syndrome, fertility impairment, and pregnancy Class C toxicity embryotoxicity in rats and rabbits ; Drug Facts and Comparisons, 1999 ; . There were only 14 humans treated for exposure to veterinary formulations of levamisole with no deaths as opposed to 26, 000 animals treated for exposure in reports to the FDA's CVM from 1987 to 1997. Overall, there is some limited evidence of embryotoxicity but little showing of acute toxic effects. Summary Of the three substances considered, Ivermectin has the longest withdrawal times for dairy cattle. The public health implications of helminth infections must also be taken into consideration. Ascaris nematodes treatable with ivermectin and fenbendazole ; infect humans through soil, vegetation, dust, water, or even objects to that the parasite's eggs have attached that are then ingested by humans or possibly inhaled ; , especially preschool children. Trichostrongylus infection treatable with benzimidizoles, ivermectin, or levamisole ; can similarly be acquired through oral infection from soil or vegetation. Anthelmintic treatment along with sanitation and pasture management have been recommended as suggested control measures Acha and Szyfres, 1987 ; . Human outbreaks of giardiosis--caused by a parasite effectively treated with fenbendazole in calves--have been attributed to contamination of drinking water by pasture run-off O'Handley, et al., 1999 ; . 5 ; The effects of the substance on biological and chemical interactions in the agroecosystem, including the physiological effects of the substance on soil organisms including the salt index and solubility of the soil ; , crops and livestock. The risks associated with chemical treatment of parasites include 1 ; immediate non-target effects, 2 ; obligation for repeat treatments, 3 ; potential risk to domestic animals and human health, 4 ; target and levemir. 26608 THE HELDRICH 4844 THE HOLLINGER CORPORATION 3331 THE HOUSE OF QUESTA 13908 THE INSTITUTE FOR SUPPLY MANAGEMENT 4846 THE INTERDEPENDENT UNA USA 16438 THE JIM HENSON COMPANY 8634 THE JOHNSON CORPORATION 24338 THE JORDAN, EDMISTON GROUP 19027 THE KALEEL JAMISON CONSULTING GROUP 4848 THE KNOTTS COMPANY INC. 18726 THE LAB. OF ANALYTICAL CHEMISTRY 14384 THE LANCET 26808 THE LEADERSHIP AND TRAINING CO. LTD 10772 THE MEMORY LIQUIDATORS 16718 THE MIDDLE EAST OBSERVER 20518 THE MITCHELL PARTNERSHIP 19028 THE MULVANEY GROUP 20530 THE NATIONAL RESOURCE CENTER 13949 THE NATIONAL SMALL INDUSTRIES CORP. 14379 THE NEW ENGLAND JOURNAL OF MEDICINE 6488 THE ORDER CENTER - COREL CORP. 26810 THE OXFORD GROUP 10993 THE PACK AMERICA CORPORATION 20187 THE PEAK TECHNOLOGIES GROUP, INC. 23426 THE PERFORMANCE INSTITUTE 3337 THE PERRIER GROUP OF AMERICA 16036 THE PETRAK GROUP S.A. 4856 THE PHILADELPHIA NATIONAL STAMP EX. 15853 THE PHILLIPS GROUP 24106 THE PORTA GROUP 11718 THE PRINGLE ELECTRICAL MANUF.CO. 17058 THE Q GROUP 13656 THE RIVERSIDE GROUP 21010 THE RYE TOWN HILTON NEW BRUNSWICK ARLINGTON SURREY TEMPE NY NEW YORK THREE RIVERS NEW YORK TROY BERKELY HEIGHTS BEIJING NEW YORK LEICESTERSHIRE EL SEGUNDO CAIRO ONTARIO NEW YORK CORAL SPRINGS NEW DELHI WALTHAM BUFFALO OXFORSHIRE NEW YORK HASBROUCK HEIGHTS ARLINGTON NEW YORK LONDON BROOMALL NEW YORK EXETER PA NEW YORK ROCHESTER RYE BROOK PA NY NY United States of America United States of America United Kingdom United States of America United States of America United States of America United States of America United States of America United States of America United States of America China United States of America United Kingdom United States of America Egypt Canada United States of America United States of America India United States of America United States of America United Kingdom United States of America United States of America United States of America United States of America United Kingdom United States of America United States of America United Kingdom United States of America United States of America United States of America United States of America. As a drench, levamisole is added to water at the rate of 03 to percent 10 ml per gallon ; for one day only and levetiracetam.

Ii - levamisole systemic ; levamisole systemic ; * some commonly used brand names are: in canada!

A more realistic way to eliminate the issue is to make sure that any product for which royalty payments are made is covered by the license. This may be done by having the licensee submit all royalty payments using a transmittal that specifically states that payments are being made for products covered by the license. If the licensee wants protection under the license, the licensee needs to concede that all products are covered. In this manner, the licensee could not later use the issue of coverage under the license as a basis to seek relief under the Declaratory Judgment Act. It should be noted that accepting payment under such a payment structure could be interpreted as a concession on the part of the licensor that the products are covered. Thus, using this payment structure requires the licensor to carefully monitor royalty payments to ensure that the payments only relate to products that the licensor intends to be covered under the license. A second factor the Supreme Court used as a basis for its holding that declaratory judgment jurisdiction existed is that MedImmune made its payments "under protest." In doing so, the Supreme Court did not seem bothered by prior case law, 24 which held that making payments under protest is not sufficient to establish jurisdiction.25 In MedImmune, the "under protest" factor stemmed principally from MedImmune's March 8, 2002 letter, which provided: Dear Sean: This is a follow-up to our letter of February 13, 2002, which responded to your January 7, 2002 letter to Michael Richman regarding Genentech's U.S. Patent No. 6, 331, 415B1 the "`415 patent" ; . To date, we have not yet received any response to the questions we asked in our February 13th letter. As we then indicated, we require responses to our inquiries and the documents we requested in order to evaluate your claim that MedImmune owes royalties to you pursuant to our June 4, 1997 agreement. As you know we wired you a payment on March 4, 2002 in the amount of $ . Such payment, however, was made under protest and with reservation of all of our rights. We expect an answer to our questions immediately so that we may evaluate how further to proceed. Very truly yours, s William C. Bertrand, Jr.
Dear Erik, Basically, it means that you didn't pay them, but they decided under the circumstances that it's okay. It is an amount you owed, but they forgave the debt and it leaves a gray mark on your credit report. If they wanted their money and you simply didn't pay, then it would leave a black mark on the report, which is much worse. I'd strongly suggest that you get the agreement in writing, Erik. That way they can't come back and try to collect it later if some new manager takes over and attempts to start the whole thing up again. - Dave Dear Dave, What do you think about interest-only mortgages? The idea is that you invest what you would normally pay toward principal over time, and your house will increase in value regardless of principal pay-down. Your investment will grow and increase your overall net worth, as well as giving you flexibility in making payments toward the principal. Taylor via email Dear Taylor, I understand the idea behind interest-only loans, and I think they're stupid. The best thing you can do is become debt-free on your home as quickly as possible. Live like no one else, so that later you can live like no one else. This is your HOME. This is where your kids live, and you're talking about trying to and licorice.

The treatment options for patients with RA have increased significantly in the past five years with the widespread use of anti-TNF blockers. Further therapies are now becoming available. In 10 years time more biological agents are likely to be used, much earlier than they are at present. A version of this article with references can be found in the Reference Section on the website supporting this business briefing touchbriefings. This is the seventh appearance of the tri-point perspective articles in Endocrine News. Past topics have been: Obesity Polycystic Ovary Syndrome Diabetes Androgen Therapy for Women Cardiovascular Disease Vitamin D's Role as a Hormone The topics, authors, and outside reviewers are selected by The Endocrine Society's Research Affairs Committee RAC ; to explore subject areas from three different angles--that of the basic researcher, the clinical researcher, and the physician-in-practice. The authors write their articles independently. The drafts are then reviewed by contributing co-editors and by independent experts in the specific topic area. Endocrine News staff would like to thank the efforts of Dr. Steven Grinspoon, RAC Co-Chair, and Dr. Ellen Seely, Co-Editor, for their dedication in developing this series for our readers. If you have any comments about this feature, please email EndocrineNews endo-society . If you wish to submit a letter to the editor, write to ENLetters endosociety. Letters should not exceed 200 words and, if published, may be edited for space and clarity. * Archived issues of the Tri-Point series can be found on the Endocrine News Web site, endo-society news endocrine news and linezolid.

The large ribosomal subunit. Crystal structures of the large ribosomal subunit in complex with different macrolides reveal that the antibiotics bind at the entrance to the exit tunnel 3, 4, close to the peptidyl transferase centre 5, 6. In accordance with that, an increased dissociation of peptidtyl-tRNA has been reported in the presence of the drugs 7, 8, 9, Furthermore, there is a correlation between macrolide structure and the length of the aborted peptide chains 10 and polysomes are immune to the antibiotics 11. Erythromycin is the most extensively characterised macrolide and is produced in nature by the soil actinomycete Saccharopolyspora erythraea formerly Streptomyces erythraeus ; 12. S. erythraea protects its own ribosomes from erythromycin by dimethylating a specific adenine residue located in the drug binding site in 23S rRNA position 2058, Escherichia coli numbering ; 13, 14, 15. Methylation is carried out by a methyl transferase encoded by the ermE gene and considerably lowers the binding affinity of erythromycin and of other macrolide, lincosamide and streptogramin B MLSB ; antibiotics 15, 16, 17. There are approximately 40 erm erythromycin ribosome methylation ; genes known in pathogenic bacteria and methylation of 23S rRNA is the most widespread resistance mechanism to macrolides 2, 18 . The second most important resistance mechanism is enhanced antibiotic efflux mediated by transporter proteins, while enzymatic modification of the drugs seems to be less significant 2, 18, 19. A fourth proposed mechanism is the expression of short specific cis-acting peptides, which confers low-level resistance to macrolides but its existence remains to be proven in clinical isolates 20, 21, 22. The most well studied erm gene is ermC from Staphylococcus aureus and ErmC synthesis is induced by erythromycin 23. The ermC mRNA contains a small open reading frame ORF ; in the ermC leader region encoding a 19 amino acids long peptide, followed by the ORF of the methyl transferase. In the absence of erythromycin, the transcript assumes a translationally inactive conformation. The small ORF in the leader region is translated while synthesis of ErmC is initiated at a very low frequency since the ribosome-binding site and the start codon of the ErmC ORF are sequestered in a hairpin structure Fig. 1 a . the presence of erythromycin, in contrast, a ribosome carrying the macrolide and translating the small ORF stalls when the first nine codons have been read. This causes a conformational change of the secondary structure of the ermC transcript, which allows for ErmC synthesis Fig. 1 b 23, 24. Stabilisation of the ermC transcript is a second effect of the stalled ribosome 25, 26 and prolongs the mRNA half-life about twenty-fold in Bacillus subtilis 26. In order to induce and sustain ErmC synthesis, both erythromycin-carrying ribosomes and erythromycin-free ribosomes are required. This suggests the existence of an optimal erythromycin concentration at which the induction rate is the fastest 27, 28 ; at low drug concentrations the number of translationally active ermC transcripts is low and at high drug concentrations the number of translationally active ribosomes is low. Another question is how the putative ermC transcript stabilisation contributes to induce resistance. Here, we model mathematically the induction dynamics of ErmC synthesis and the subsequent transformation of the bacterium into an MLSB-resistant cell. We discuss the effect of the binding affinity of a stalled ribosome to the leader sequence of the ermC mRNA, of the activity of the methyl transferase and of the concentration of erythromycin. We predict that an erythromycin concentration of the order of 10-7 M maximises the induction response rate as reflected in the most rapid boost of the concentrations of methylase and resistant ribosomes. This is in good.
So i decided to stop the medicated food and use the pure levamisole instead and liothyronine and levamisole.
1. Laurie JA, Moertel CG, Fleming TR et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 1989; 7: 14471456. Moertel CG, Fleming TR, Mcdonald JS et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352358. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444 Wolmark N, Rockette H, Fisher B et al. The benefit of leucovorinmodulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 1993; 11: 18791887. International Multicentre Pooled Analysis of Colon Cancer Trials IMPACT ; . Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345: 939 O'Connel MJ, Laurie JA, Kahn M et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with highrisk colon cancer. J Clin Oncol 1998; 16: 295300. Haller DG, Catalano PJ, Macdonald JS et al. Fluorouracil, leucovorin, and levamisole adjuvant therapy for colon cancer: Five years final report of INT-0089. Proc Soc Clin Oncol 1998; 17: 256 Abstr 982 ; . 8. O'Connell MJ, Mailliard JA, Khan MJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 5: 246 Zaniboni A. Adjuvant chemotherapy in colorectal cancer with highdose leucovorin and fluorouracil: impact ondisease-free survival and overall survival. J Clin Oncol 1997; 15: 2432 de Gramont A, Banzi M, Navarro M et al. Oxaliplatin FU LV in adjuvant colon cancer: results of the international 11.

Using general primers. Twenty-five of the 26 samples negative by slot blot were subject to analysis by P C Table 3 ; . O these, 11 o f 25 gave a b a samples were r u n gel. These primers enable the detection of a range of H P types, b u t h analysis was confined to HPV-6, -11 a n d -16 to permit c o m with detection by slot blotting. S o u blot h y b revealed that four of these samples were positive for HPV-16 a n d the r e m seven were and lomefloxacin.
Register login all prices are in us dollars buy ergamisol levamisole ; at discount canada pharmacy store ergamisol levamisole ; this product requires a valid prescription tell your friends about this product and you and your referral can each earn store credit * this offer is valid for prescription items only * b: brand g: generic all prices in usd drug overview effects - how it works in the body side effects counterindications interactions similar drugs of ergamisol major drug manufacturers from where can one get ergamisol levamisole. Number Tested 50 Zevin S, Jacob P and Benowitz N. Cotinine effects on nicotine metabolism. Clinical Pharmacology & Therapeutics, 1997 June 61 6 ; : 649-54. Zuccaro P, Pichini S, Altieri I, Rosa M, Pellegrini M and Pacifici R. Interference of nicotine metabolites in cotinine determination by RIA. Clinical Chemistry, 1997 Jan 43 1 ; : 180-1. Benowitz NL. Cotinine as biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews, 1996 18 2 ; : 188-204. Curvall M and Vala FK. Nicotine and metabolites: analysis and levels in body fluids. Nicotine and related alkaloids: absorption, distribution, metabolism and excretion. Edited by Gorrod JW and Wahren J. Published in 1993 by Chapman & Hall, London. ISBN 0 142 55740 1. ERGAMISOL levamisole hydrochloride ; , a colon cancer drug, and LEUSTATIN cladribine ; , for hairy cell leukemia. Prescription drugs in the psychotropics central nervous system ; field include antipsychotic drugs RISPERDAL risperidone ; and HALDOL haloperidol ; , and CONCERTA methylphenidate ; for attention deficit hyperactivity disorder. Prescription drugs in the pain management field include DURAGESIC fentanyl transdermal system, sold abroad as DUROGESIC ; , a transdermal patch for chronic pain; and ULTRAM tramadol hydrochloride ; , an analgesic for moderate to moderately severe pain. Prescription drugs in the urology field include DITROPAN XL oxybutynin ; for the treatment of overactive bladder. Johnson & Johnson markets over 100 prescription drugs around the world, with 31.0% of the sales generated outside the United States of America. Thirty-three drugs sold by the Company had 2001 sales in excess of million, with 20 of them in excess of 0 million. Pharmaceutical segment sales in 2001 were .9 billion, an increase of 17.3% over 2000 including 21.3% growth in domestic sales. Operationally, international sales increased 14.2% but were partially offset by a negative currency impact of 4.9%. Worldwide sales gains in local currency of 19.0% were partially offset by a negative currency impact of 1.7%. Sales growth reflects the strong performance of PROCRIT EPREX, RISPERDAL, DURAGESIC, CONCERTA, REMICADE, ULTRAM, TOPAMAX, and ACIPHEX PARIET. Sales of PROCRIT EPREX accounted for 10.4% of total Company revenues for 2001. During the fourth quarter of 2001, the Company received U.S. Food and Drug Administration FDA ; approval for ORTHO EVRA, the first birth control patch. ORTHO EVRA is a thin, beige patch that delivers continuous levels of the hormones norelgestromin and ethinyl estradiol progestin and estrogen, respectively ; through the skin and into the bloodstream. The patch is worn for one week at a time and is replaced on the same day of the week for three consecutive weeks. The fourth week is "patch-free." The Company also filed several new drug applications with the FDA in December 2001. These include LEVAQUIN for the treatment of nosocomial pneumonia, an orally disintegrating formulation of RISPERDAL and a synthetic oral solution of REMINYL for Alzheimer's disease. Pharmaceutical segment sales in 2000 were .7 billion, an increase of 12.7% over 1999 including 21.4% growth in domestic sales. Operationally, international sales increased 7.6% but were more than offset by a negative currency impact of 8.9%. Worldwide sales gains in local currency of 16.1% were partially offset by a negative currency impact of 3.4%. Sales growth reflects the strong performance of PROCRIT EPREX, RISPERDAL, DURAGESIC, LEVAQUIN, REMICADE, ULTRAM, TOPAMAX, ACIPHEX PARIET and the oral contraceptive line of products. Sales growth was partially offset by restricted access to or limited indications for PROPULSID PREPULSID in a number of markets around the world. Pharmaceutical segment sales in 1999 were .2 billion, an increase of 20.7% over 1998, including 28.9% growth in domestic sales. International sales increased 9.4% as sales gains in local currency of 13.5% were offset by a negative currency impact of.

I had an outbreak of camalanus worms and had to research in order to figure out how to use the bottle of powdered form of levamisole i found at our local farm store. The first studies on 9 bp deletion suggested that this deletion defines haplogroup B. However, later studies showed that this deletion also exists in haplogroup I. Nine bp deletion in a background of haplogroup I have reported from Mediterranean, Italy and Liberia so far 40 ; . Since Iran is geographically close to Mediterranean, the possibility of diffusion of this marker to Iran could be considered. Detection of no 9 deletion in this study, suggests that this haplotype has no eastward diffusion and therefore this haplotype is young. The 9 bp deletion can tell us about migration routes of early humans. It is believed that humans left Africa to India through Saudi Arabia, Iraq, Iran and Pakistan 6085 kilo years ago 11, 42 ; . Most of Africans have no deletion. Those having it also have African motifs, which are different from Asian ones 22 ; . Therefore, if the above rout is correct, one will expect no deletion in populations located on the route or if any deletion exists, it must have African motif ; . No published report was found on screening of this marker in Saudi Arabia and Iraq. But the frequency of this marker in Pakistan is zero 20 ; . Roychodhury also found no deletion in India and suggested that the absence of this marker was an evidence for migrating from Africa to India 35 ; . Since we did not detect any deletion in Iran either, the migration from Africa to India through Iran is further supported. A number of other migrations occurred after agricultural revolution. Agriculture has begun in three regions of the world independently. The oldest one is Fertile Crescent in Middle East. This crescent contains Palestine, north of Syria and west of Iran. A few of historians believed that agriculture introduced to India 4. Oral anthelmintic for sheep and cattle active constituent: 32 g l levamisole hydrochloride equivalent to 27 g levamisole ; for the control of levamisole susceptible roundworms and lungworms in sheep and cattle including those which are resistant to benzimidazoles. In the group which received no added vitamin E but also which received tocopherol. This latter substance, there prevent the cholesterol deposition. It is of little import conclusion that the basal diet was not devoid of vitamin E.

For advice contact the National Poisons Centre 0800 POISON 0800 764 766 ; or a doctor. The information presented below pertains to the following individual ingredients, and not to the mixture s ; . Only information about the ingredients that are expected to contribute significantly to the potential health hazard profile of the formulation s ; are presented: Levamisole is an anthelmintic and immunostimulant. Acute exposure to levamisole may cause nausea, vomiting, diarrhoea, abdominal pain, dizziness, or headache. Chronic exposure may cause hypersensitivity reactions including fever, flu-like syndrome, arthralgia, muscle pain, skin rashes, or cutaneous vasculitis, CNS effects including headache, insomnia, dizziness, or convulsions, haematological abnormalities including agranolucytosis, leucopenia, or thrombocytopenia, or gastrointestinal effects including abnormal taste in the mouth. Oxfendazole is not-irritating, not-sensitizing, and practically not-toxic acutely. Based on animal studies, oxfendazole may cause liver, bone marrow, testes, gastrointestinal tract, and blood cell effects following chronic exposure. All selenium salts can produce toxicity by ingestion, inhalation, and dermal absorption; however, acute poisonings with selenium and its salts are rare.